KEY wk 5 lec 2 Flashcards

1
Q

types of obstructive vs restrictive lung diease

A

obstructive:
-bronchial asthma
-COPD (chronic bronchitis and emphysema)
-bronchiectasis

restrictive:
-acute: ARDS (diffuse alveolar damage)
-chronic: idiopathic pulmonary fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

restrictive vs obstructive lung disease

A

obstructive: cant exhale bc airway narrow or obstructed; trap air in lungs (air trapped in alveoli)

restrictive: cant inhale bc lung expansion reduced from stiff lung tissue or impaired respiratory mechanics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pulmonary function tests (2)

A

spirometry
bodyplethysmogrpahy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

FEV1/FVC in obstructive vs restrictive

A

obstructive: reduced

restrictive: normal or increase (“physiological”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TLC (total lung capacity) and RV (residual volume) and FRC (functional residual capacity) in restrictive vs obstructive lung disease

A

obstructive: increased by air trapped (hyperinflation)

restrictive: low lung volumes; decreased both because lung cant expand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

bronchial asthma (obstructive)

pathophysiology

irreversible or reversible?

inflammatory cell involved

A

episodic airway obstruction, hyper responsiveness and inflammation

reversible

eosinophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

bronchial asthma “trias” definition

A

chronic inflammation

reversibility of obstructive ventilatory impairment

obstructive ventilatory impairment and bronchial hyperactivity (sx)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

risks for bronchial asthma

A

polygenic inheritance (i.e. Beta receptor) and environment and atopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

sx of atopy and test

A

Nose: Allergic rhinitis

Eye: Allergic conjunctivitis

Skin: Eczema

Nose: Hey fever

Allergies (food, contact, inhalation)

Positive skin tests (prick tests)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

triggers of bronchoconstrictions

A

allergens

infections in upper airays

inhalatory irritants

anxiety, cold air, GERD, exercise

drugs esp NSAIDS, aspirin

food preservatives (sulphites)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

classification of asthma

A

allergic vs non allergic

  1. Allergic - Atopic
  2. Nonallergic – Nonatopic 3. Drug-induced asthma
  3. Occupational asthma
  4. Cardiac asthma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

allergic asthma

sx

type _ hypersensitivity

causes

A

kids, hay fever, eczema

type I hypersenstiivity

pollens, dusts, drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pathogensis of allergic asthma

ILs? Th_? Ig_?

A

hyperactive airway constricts to stimuli; increase airway resistance

type 1 hypersensitivity

CD4+ and Th2 release IL-4 and IL-5 which then stimulate eosinophils –> produce IgE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

nonallergic asthma

what levels are normal

causes

A

adults

NOT type 1 hypersensitivity; IgE is normal

Th17 and Th1 drive infalmmation

exercise, cold air, drugs, GERD, viral (rhinovirus, parainfluenza), hormonal, pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

early vs late stage of asthma

A

early: bronchoconstriction via histamine, prostaglandin, leukotrienes

late: neutrophils release proteases and eosinophils release major basic protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

mechanisms of airway obstruction

A

hyper responsive, inflammation, collagen deposition, smooth muscle constriction vascular proliferation, edema, goblet cell metaplasia and mucus hypersecretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

2 components of airway hyperresponsiveness

A
  1. functional: hyper responsive to direct smooth muscle acting agents like histamine or methacholine
  2. structural: wall thickness (smooth muscle hypertrophy, collagen deposition, edema, inflammation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

gross vs microscopic morphology of asthma

A

gross: status asthmatics= hyperinflated lungs, mucus plugging

microscopic: charcot-leyden crystals (from major basic protein), curschmann spirals, eosinophil infiltrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

spirometry in asthma exacerbation (obstructive)

FEV1/FVC

PEF (peak expiratory flow)

residual volume

and reversibility from

A

FEV1/FVC: reduced

PEF reduced

RV increased

reversible via bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

spirometry between exacerbations in early vs late asthma

A

early= normal

late=

low peak expiratory flow (PEF)

reduced FEV1/FVC

increase residual volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

arterial blood gases in asthma during exacerbation vs in between exacerbations

A

during: CO2 low; hyperventilate (compensatory), CO2 rises if respiratory failure (later stages)

between: PaO2 and PaCO2 are normal;

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

classic triad of symptoms in asthma

when are they worse and because of what hormone

A

wheeze, cough, dyspnea

worse or only present at night becasue of cortisol drop

status asthmaticus= prolonged attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

face findings in asthma

A

Dark rings under the eyes
(“allergic shiners”)

Dark transverse crease on the nose (“allergic salute”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

2 types of COPD

A
  1. chronic bronchitis
  2. emphysema

airflow limitation that’s not reversible; progressive and inflammatory

25
Q

risk factors for COPD

A

genes (alpha-1-antitrypsin deficiency)

tobacco smoke *** BIGGEST

occupational dusts

air pollution

26
Q

4 evens of COPD

A
  1. inflammatory and immune cell recruitment to airways
  2. proteinase damage ECM in airways
  3. cell death via oxidant induced damage
  4. disordered repair of elastin (emphysema)
27
Q

cellular mechanisms in COPD

A

chronic bronchitis: larger airways, airway remodelling, mucus secretion

emphysema: terminal airways, loss of alveoli, loss of elastin

both from apoptosis, inflammation, immune response, oxidants

28
Q

chronic bronchitis

time line

causes

types

A

productive cough for > 3 months

cigarettes irritate airway and increase and hyperplasia of mucus glands, metaplasia of goblet cells, thicken submucosal layer

simple, obstructive and asthmatic

29
Q

pathology in chronic bronchitis

A

airway obstruction

air trapping- hyperinflation

30
Q

emphysema

what changes to lungs

A

lose pulmonary parenchyma –> lose elastic recoil –> exhalation; airway collapse –> air trapping

lose alveolar septa and airway walls and dilate terminal airways

31
Q

morphology of emphysema

A

dilation of airspaces

bull form in pleural space

32
Q

2 types of emphysema and their causes and what area of lungs are effected

A

centriacinar emphysema from smoking affect respiratory bronchioles in upper lobes

panacinar emphysema from alpha1-antitrypsin deficiency affect alveoli, alveolar ducts, respiratory bronchioles in lower lobes

33
Q

CT patterns of emphysema

A
  1. centrilobular (upper lobe; smoking)
  2. pan lobular (diffuse loss, lower lobe; A1 antitrypsin deficiency)
  3. paraseptal (smoking)
34
Q

blue bloater vs pink puffer

A

blue (chronic bronchitis): peripheral edema (fat), RV heart fail, cyanosis, hypercapnia

pink (emphysema): hypercapnia, hypoxemia, minimal cyanosis, muscle wasting (skinny)

35
Q

obstructive bronchitis vs emphysema

A

obstructive bronchitis:
-chronic productive cough
-hypercapnia
-right ventricular failure
-peripheral edema

emphysema:
- dyspnea
-hypoxemia
-hypercapnia
-hyperventilation

36
Q

spirometry on obstructive ventilatory impairment

A

FEV1 is reduced

FVC is normal of slightly reduced

FEV1/FVC is reduced to < 0.7

37
Q

complications of COPD

A

pulmonary hypertension (from hypoxia induced vasospasm)

cor pulmonale (right sided heart failure bc of pulmonary hypertension)

mismatched ventilation-perfusion (shunt blood to areas of poor ventilation)

respiratory failure

38
Q

bronchiectasis (obstructive lung disease)

what forms and which is most common

A

irreversible airway dilation

focal or diffuse

cylindrical or tubular (most common), varicose or cystic

39
Q

2 compoennts/ causes of bronchiectasis

A

infection and obstruction

infection destroys smooth muscle and elastic fibers of airway wall

40
Q

non infectious vs infectious bronchiectasis and what type of presentation

A

non-infectious (obstruction of airway) causes focal bronchiectasis
1. extrinsic (compressed by adjacent lymphadenopathy or parenchymal tumor mass)
2. intrinsic (airway tumor or aspirated foreign body)

infectious disease or systemic causes diffuse bronchiectasis (I.e HIV immunodeficiniey, mycobacterial, antitrypsin genes, autoimmune, IBD, rheumatoid arthritis, idiopathic)

41
Q

pathogenesis of infectious diffuse bronchiectasis; “vicious cycle hypothesis”

A

infection susceptibility- poor mucocilliary clearance

microbial colonization (p. aeruginosa)

severe infection (pneumonia from Bordetella pertussis or Mycoplasma pneumoniae)

chronic inflmamtion

mediators released from bacteria

42
Q

gross and microscopic morphology in bronchiectasis

A

gross: dilate away, esp. lower right lobe, airways extend into pleural space

microscopic: inflammatory infiltrate and tissue destruction

43
Q

sx and signs of bronchiectasis

A

dyspnea, chronić cough with sputum, hemoptysis

finger clubbing (pulmonary osteoarthropathy), hypoxemia, hypercapnia, chest radiograph shows parallel lines= thickened bronchial walls

44
Q

complications of bronchiectasis

A

recurrent infections (i.e. antibiotics)

hemoptysis –> hemorrhage

rare: pulmonary hypertension, abscess formation, amyloidosis

45
Q

restrictive lung disease spirometry findings

A

reduction of all volumes

FEV1/FVC is normal

46
Q

2 categories of restrictive lung disease

A

extra pulmonary (obesity, chest deformity, kyphoscoliosis)

intrapulmonary (primary or secondary, acute ARDS or chronic)

47
Q

intrapulmonary restrictive lung disease cause a reduction in

A

diffusion capacity

48
Q

pathogenesis of intrapulmonary restrictive lung diseases

initial to late phase

A

environmental, idiopathic, genetic

initial phase: inflammation: alveolitis (lymphocytes, neutrophils)

late phase: fibrosis: alveoli’s (lymphocytes, neutrophils)

49
Q

ACUTE: ARDS (acute restrictive lung disease) - AKA Diffuse Alveolar Damage

secondary too

findings

A

short time period (mins to days)

second to major systemic insult (i.e. sepsis, shock)

diffuse pulmonary infiltrates and hypoxemic respiratory failure)

increased vascular permeability

necrosis of cells

redution in diffusion capacity

50
Q

3 stages of diffuse alveolar damage (ARDS)

A
  1. exudative stage (protein and necrotic cells on alveolar septae form hyaline membranes)
  2. proliferative (type II pneumocytes undergo hyperplasia)
  3. fibrosis
51
Q

4 main causes of diffuse alveolar damage (ARDS)

A
  1. sever pulmonary infetion
  2. aspiration
  3. sepsis
  4. severe trauma with shock

other: viral, acute pancreatitis, acute interstitial pneumonitis….

52
Q

sx and signs of diffuse alveolar damage (ARDS)

A

dyspnea, pink frothy sputum

signs: crackles, hypoxemia, diffuse alveolar infiltrates

high mortality
-develop fibrosis –> chronic restrictive lung disease - pulmonary hypertension

53
Q

chronic restrictive lung disease

A

inflam, fibrosis, impaired gas exchange (low diffusing capacity from carbon monoxide), obstructive ventilation impairments (decreased and normal FEV1/FVC)

54
Q

causes of interstitial lung disease

A

autoimmune (i.e. lupus)
idipathic
work (asbestosis, silica, coal)
drugs

55
Q

chronic idiopathic pulmonary fibrosis (restrictive)

findings on x ray (initial and late)

A

initial: ground-glass (exudates in alveoli)

later: honeycomb lung (fibrosis of alveolar septal, parenchyma, and cobblestone pleural surface)

56
Q

7 histological categories of idiopathic interstitial pneumonia

A

Usual interstitial pneumonia (UIP) Nonspecific interstitial pneumonia (NSIP) Organising pneumonia (OP)*
Diffuse alveolar damage (DAD) Desquamative interstitial pneumonia (DIP)** Respiratory bronchiolitis (RB)
Lymphocytic interstitial pneumonia (LIP)

57
Q

sx of idiopathic interstitial pneumonia

A

dyspnea on exertion
dry cough
tachypnea

signs: bibasilar end-inspiratory crackles, finger clubbing, right sided heart failure, diminished lung volume

58
Q

pathogenetic implications for therapy for idiopathic interstitial pneumonia

A

immunosuppressive therapy (corticosteroids etc)

biological therapy (monoclonal antibodies- RTK inhibitors)

long term home oxygen therapy

lung transplant